Health Research Alliance
Browse
ISC 2023 ICAM-1 poster 01-27-2023_3.pdf (1.46 MB)

ISC 2023 ICAM-1 poster 01-27-2023_3.pdf

Download (1.46 MB)
poster
posted on 2023-06-05, 21:47 authored by Jens Witsch, David Roh, Stephanie Oh, Costantino Iadecola, Ramon Diaz-Arrastia, Scott E. Kasner, Stephan Mayer, Santosh B Murthy

sICAM-1 serum levels on admission for ICH were associated with increased odds of poor outcome and  hematoma expansion. 

This suggests that admission sICAM-1 levels may be a  marker of poor outcomes in the hyperacute phase of ICH.  Future studies are needed to shed light on the  mechanisms linking sICAM-1 with radiological and clinical  outcomes to determine whether sICAM-1 may be a viable  therapeutic target 

History

Grant ID

23CDA1053561

Usage metrics

    American Heart Association

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC